Jeonjinbio Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Taehun Lee
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 3.5% |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
No updates
Recent updates
Jeonjinbio Co., Ltd.'s (KOSDAQ:110020) Price In Tune With Revenues
Jan 07There's Been No Shortage Of Growth Recently For Jeonjinbio's (KOSDAQ:110020) Returns On Capital
Oct 25With A 38% Price Drop For Jeonjinbio Co., Ltd. (KOSDAQ:110020) You'll Still Get What You Pay For
Jun 07Shareholders Should Be Pleased With Jeonjinbio Co., Ltd.'s (KOSDAQ:110020) Price
Apr 03Is Jeonjinbio (KOSDAQ:110020) Using Debt Sensibly?
Apr 13If You Had Bought Jeonjinbio (KOSDAQ:110020) Shares A Year Ago You'd Have Earned 101% Returns
Feb 19CEO
Taehun Lee (51 yo)
no data
Tenure
Mr. Tae-Hun Lee founded Opus Pictures Co., Ltd. in 2005 and serves as its Chief Executive Officer and Producer. Mr. Lee serves as Chief Executive Officer of Jeonjinbio Co., Ltd.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/09 08:41 |
End of Day Share Price | 2025/01/09 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jeonjinbio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|